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The glomerular basement membrane (GBM) is a crucial component of the 
kidney’s filtration barrier that separates 
the vasculature from the urinary space. 
During glomerulogenesis, the GBM is 
formed from fusion of two distinct base-
ment membranes, one synthesized by 
the glomerular epithelial cell (podocyte) 
and the other by the glomerular endo-
thelial cell. The main components of the 
GBM are laminin-521 (α5β2γ1), collagen 
α3α4α5(IV), nidogen and the heparan 
sulfate proteoglycan, agrin. By studying 
mice lacking specific GBM components, 
we have shown that during glomerulo-
genesis, laminin is the only one that is 
required for GBM integrity and in turn, 
the GBM is required for completion of 
glomerulogenesis and glomerular vascu-
larization. In addition, our results from 
laminin β2-null mice suggest that lam-
inin-521, and thus the GBM, contribute 
to the establishment and maintenance of 
the glomerular filtration barrier to plasma 
albumin. In contrast, mutations that affect 
GBM collagen IV or agrin do not impair 
glomerular development or cause immedi-
ate leakage of plasma proteins. However, 
collagen IV mutation, which causes 
Alport syndrome and ESRD in humans, 
leads to gradual damage to the GBM 
that eventually leads to albuminuria and 
renal failure. These results highlight the 
importance of the GBM for establishing 
and maintaining a perfectly functioning, 
highly selective glomerular filter.
Introduction
Human kidneys generate an enormous 
primary filtrate of about 180 liters from 
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the approximately 900 L of blood that 
pass through them on a daily basis. Due 
to resorption of water and solutes by the 
tubular epithelial cells of the kidney, this 
primary filtrate is concentrated to a uri-
nary output of only 1–2 L. The glomeru-
lar filtration barrier, which lies between 
the vasculature and the urinary space, 
retards the passage of plasma proteins, 
primarily of albumin and immunoglob-
ulins, while ensuring the efficient flow 
of water and small solutes that comprise 
the primary filtrate. Since the realization 
that the glomerular capillary wall consists 
of two cells, podocyte and endothelium, 
separated by an extracellular matrix called 
the glomerular basement membrane 
(GBM), there have been vigorous debates 
about which of these three layers serves as 
the major barrier to plasma proteins.1 In 
this review, I will summarize our current 
understanding of the cellular and extracel-
lular components of the glomerular capil-
lary wall and focus on the composition of 
the GBM as it relates to glomerulogenesis, 
permselectivity and kidney disease.
The Glomerular  
Filtration Barrier
The glomerular filtration barrier (Fig. 1) is 
a three-layered structure that lies between 
the vasculature and Bowman’s space. 
Within the glomerulus, it is the only sepa-
ration between the bloodstream and the 
urine. The GBM is a specialized extracel-
lular matrix situated between the podo-
cytes and endothelial cells, which, during 
glomerulogenesis, synthesize and secrete 
components of the GBM. Furthermore, 
both cell types are important for 
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of filamentous plugs in the fenestrations. 
These plugs are thought to be composed 
of a form of glycocalyx (a sugary coat) 
assembled by the glomerular endothelial 
cells at their cell surfaces. These fenestral 
plugs have been hypothesized to serve as 
an impedance to the passage of plasma 
proteins and therefore an important com-
ponent of the glomerular filtration barrier 
to albumin.8-10
Glomerular Basement Membrane 
(GBM)
The GBM is, in some ways, a typical base-
ment membrane: it has an electron-dense 
lamina densa when viewed by transmis-
sion electron microscopy, and it is formed 
by protein-protein interactions among the 
same classes of macromolecules found in 
all other basement membranes. However, 
the GBM also has some atypical features. 
First, it is unusually thick compared to 
most other basement membranes; as 
mentioned above, the GBM forms dur-
ing glomerulogenesis by the fusion of 
two distinct basement membranes, the 
endothelial and the visceral epithelial 
(or podocyte) basement membranes.3 
Second, the GBM has an unusual com-
position compared to most other base-
ment membranes, and this presumably 
imparts its unique functional properties. 
The GBM contains laminin, type IV col-
lagen, nidogen and heparan sulfate pro-
teoglycan (HSPG), components found in 
all basement membranes, but for some of 
these types of matrix proteins, the specific 
isoforms present in the GBM are very dif-
ferent than those found elsewhere in base-
ment membranes. Even the contiguous 
Bowman’s capsule and tubular basement 
membranes, for example, possess differ-
ent complements of isoforms compared to 
the GBM.
The GBM occupies a prime position 
within the glomerular filtration barrier 
(Fig. 1). In addition, it is very dense by 
electron microscopy. Together with struc-
tural and functional data regarding the 
GBM and other basement membranes, 
published by many different labs over a 
period of decades, we hypothesize that the 
GBM functions by (1) providing adhesive 
and signaling substrates to the adjacent 
glomerular cells (podocytes, endothelial 
and undergo a dramatic mesenchyme-
to-epithelium transition to form what is 
referred to as the renal vesicle. Activation 
of numerous important signaling path-
ways results in morphological changes to 
the renal vesicle and segmentation of the 
resulting “S-shaped” figure into the podo-
cytes, the parietal epithelial cells that form 
Bowman’s capsule,and the epithelial cells 
that comprise the tubular segments of the 
nephron.6
Glomerular Endothelial Cells
Glomerular capillaries are lined by endo-
thelial cells that are different than most, 
because they bear many fenestrations 
(Fig. 1). Fenestrations are seemingly pat-
ent “holes” in the endothelial cells that 
allow the passage of fluid across the cell 
layer. Ultrastructural analyses have shown 
that some of these fenestrations have 
wagon wheel-like diaphragms similar to 
those found in peritubular capillaries and 
in islet endothelial cells in the pancreas, 
but many of the fenestrations in glomer-
ular endothelial cells do not have dia-
phragms.7 This lack of diaphragms likely 
allows more efficient flow of plasma across 
this proximal layer of the glomerular fil-
tration barrier.
Despite the presence of what usu-
ally appear by electron microscopy to be 
unobstructed fenestrae in the glomerular 
endothelium, special methods of fixa-
tion and staining indicate the presence 
maintaining the GBM’s structure and 
function after glomerular maturation.2-4 
Although the focus of this review is the 
GBM, podocytes and endothelial cells 
will also be discussed, as all three layers 
are necessary for establishing and main-
taining an intact filtration barrier.
Podocytes
Podocytes, also called glomerular visceral 
epithelial cells, are morphologically com-
plex, nascent nephron epithelium-derived 
cells that reside within the urinary space 
(also called Bowman’s space) and are 
therefore bathed in the primary urine. 
Podocytes enwrap the outer aspect of the 
glomerular capillaries by extending nar-
row foot processes that interdigitate with 
those of adjacent podocytes. Juxtaposed 
foot processes are directly linked to one 
another by the glomerular slit diaphragms 
(Fig. 1); these derive from gradual modi-
fication and apical-to-basal migration of 
the tight junctions that originally joined 
the previously columnar, immature 
podocytes.5
Like the tubular epithelial cells of the 
nephron, podocytes are descendants of 
the metanephric mesenchyme, a popula-
tion of intermediate mesoderm-derived 
cells that are determined to form neph-
rons. At the beginning of development 
of the definitive kidney, the ureteric bud 
grows towards and into the metanephric 
mesenchyme and induces it to condense 
Figure 1. The ultrastructure of the glomerular filtration barrier. The capillary lumen is lined by 
an endothelium with fenestrations (arrowheads). The endothelium is adjacent to the ribbon-like 
glomerular basement membrane (gBM). Podocyte foot processes, which are bridged by slit dia-
phragms (arrows), abut the opposite aspect of the gBM and are surrounded by the primary filtrate 




triple helix; this is because glycine is the 
only amino acid with a side chain (a hydro-
gen) that is able to fit at the center of the 
helix. But unlike the rigid fibril-forming 
types of collagen that are associated with 
bone and tendon, for example, the six dis-
tinct collagen IV α chains contain numer-
ous interruptions of the Gly-X-Y repeats 
that are scattered throughout the collag-
enous domain. These interruptions pro-
vide flexibility to the collagen IV trimers 
and therefore to the collagen IV network, 
which is formed by covalent and non-
covalent interactions among trimers in the 
extracellular matrix.15
Besides the central collagenous region 
containing the Gly-X-Y interruptions, all 
six collagen IV α chains bear a small non-
collagenous NH
2
-terminal domain called 
7S and a larger COOH-terminal noncol-
lagenous domain called NC1. Both of 
these domains are crucial for linking tri-
mers to each other to promote collagen IV 
network formation. Moreover, the NC1 
domain plays an important role in direct-
ing the composition of collagen IV hetero-
trimers; information present within the 
NC1 domain sequence ensures that only 
three types of collagen IV trimers form: 
(α1)
2
α2, α3α4α5 and (α5)
2
α6.16
by both podocytes and endothelial cells.2 
During the early stages of glomerulogen-
esis, when glomerular endothelial cells 
are migrating towards the differentiat-
ing podocytes to begin to form the glo-
merular capillaries, and the GBM is first 
recognizable as a distinct basement mem-
brane, LM-111 and LM-511 are the major 
laminin components.13 But as capillary 
maturation begins, LM-521 is deposited 
by both podocytes and endothelial cells, 
and LM-111 and -511 are eventually elimi-
nated.13,14 The molecular mechanisms that 
drive the developmental transitions in 
laminin expression and deposition have 
yet to be discovered, but as discussed 
below, these transitions are crucial to 
ensure the establishment of a proper glo-
merular filtration barrier.
Type IV Collagen
Type IV collagen, like all collagens, is 
secreted as a trimer (also called protomer) 
composed of three α chains, the sequences 
of which include collagenous regions that 
consist of repeated Gly-X-Y amino acid 
triplets. The presence of glycine at every 
third residue is absolutely necessary to 
allow the chains to assemble into a stable 
cells and mesangial cells); (2) concentrat-
ing and presenting diffusible factors, such 
as vascular endothelial growth factor; and 
(3) contributing directly to the glomerular 
filtration barrier to albumin. These func-
tions, if correct, likely depend upon the 
composition of the GBM, which will now 
be discussed.
Laminin
Laminins are a family of large, evolu-
tionarily related glycosylated proteins 
that assemble with each other to form 
at least 15 different αβγ heterotrimeric 
macromolecules. These laminin trimers 
are synthesized and secreted by diverse 
cell types into the extracellular space. 
Laminin trimers in the most recent lam-
inin nomenclature scheme are named 
based solely on their chain composition; 
e.g., a trimer containing the laminin α5, 
β2 and γ1 chains is called laminin-521, or 
LM-521.11 Most laminin heterotrimers are 
cross-shaped macromolecules (LM-521 is 
shown in Fig. 2), with the one “long arm” 
formed by association of the α, β and γ 
chains via coiled-coil interactions and 




domains (called LN domains) that medi-
ate laminin trimer-trimer interactions in 
the extracellular space. These interactions 
lead to laminin polymerization, which 
initiates basement membrane formation. 
The ~100 kDa laminin globular (LG) 
domain at the distal end of the long arm 
(found exclusively at the COOH termini 
of α chains) mediates interactions with 
integrin and nonintegrin receptors on 
the surfaces of cells. A number of studies 
have shown that laminin polymerization 
in the extracellular space is required for 
initiation of basement membrane forma-
tion. Moreover, laminin polymerization 
via short arm-short arm interactions is 
facilitated by LG domain interactions 
with cellular receptors, likely due in part 
to the increase in effective laminin con-
centration that results at cell surfaces. 
Intracellular signaling events induced by 
laminin binding are also involved in pro-
moting laminin polymerization and base-
ment membrane formation.12
LM-521 is the major laminin found 
in the mature GBM, and it is secreted 
Figure 2. The laminin-521 heterotrimer. This full-sized cruciform laminin is composed of the α5, 
β2 and γ1 chains. globular laminin amino-terminal (Ln) domains interact with each other to facili-
tate laminin polymerization in the extracellular matrix. The α chain laminin globular (Lg) domain 
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motor neurons is crucial for development 
and organization of the neuromuscular 
junction.22 Although agrin is the major 
GBM HSPG at maturity, during glo-
merular development there appears to be a 
codistribution of agrin and perlecan, and 
then perlecan disappears from the GBM 
and becomes confined to the mesangial 
matrix.23
The GBM’s Contribution  
to  Glomerulogenesis
Evidence that the GBM plays an impor-
tant role in glomerulogenesis comes from 
our studies of laminin α5 mutant and 
transgenic mice. As alluded to above, 
during glomerulogenesis there are devel-
opmental transitions in GBM compo-
nents, including transitions from LM-111 
to LM-511 and then to LM-521, which 
is the mature isoform.13 The appear-
ance of LM-511 in the nascent GBM is 
accompanied by the abrupt removal/dis-
appearance of LM-111 by an unknown 
mechanism. When laminin α5 is knocked 
out, LM-111 is still removed, and because 
there is no polymerizing laminin trimer 
present, the integrity of the GBM is com-
promised, and it breaks down.24 Without 
a GBM, none of the three glomerular cell 
types are able to maintain their positions 
within the developing glomerulus, lead-
ing to a disorganized glomerulus (Fig. 3) 
and failed glomerular vascularization.24 
Subsequent studies of specific segments 
of the laminin α5 COOH-terminal LG 
domain reveal a previously unknown role 
for laminin α5 in mediating adhesion of 
mesangial cells to the GBM; this adhesion 
is required for maintaining the capillary 
looping that is a major anatomical charac-
teristic of the glomerular tuft.25
The GBM’s Contribution  
to  Permselectivity
Since the discovery that nephrin (NPHS1), 
a primary component of the glomerular 
slit diaphragm, is mutated in congenital 
nephrotic syndrome of the Finnish type,26 
podocytes have been the major focus of 
research aimed at defining the nature 
of the glomerular filtration barrier and 
understanding the etiology of glomeru-
lar disease. There is now known to be a 
collagen networks. However, analysis 
of single and double nidogen-1 and -2 
knockout mice proved that basement 
membranes can form in the absence of 
either or both nidogen proteins, although 
some basement membranes su jected to 
high levels of stress during embryogen-
esis exhibit breaks and discontinuities in 
the absence of both nidogens.20 As far as 
the GBM is concerned, both nidogens-1 
and -2 are present, but little is known 
about their differential expression during 
development.
Heparan Sulfate  
Proteoglycans (HSPGs)
HSPGs consist of a protein core with 
covalently linked glycosaminoglycan side 
chains that can dramatically increase the 
molecular weight of the molecule. The 
side chains are frequently modified by sul-
fation, which confers a significant anionic 
charge to the proteoglycan and thus to the 
basement membrane (or other extracel-
lular matrix) in which the proteoglycan 
is located. Although perlecan is probably 
the most common HSPG found in most 
basement membranes, the mature GBM 
contains very little perlecan but, instead, 
contains primarily agrin.21 Agrin plays an 
important role in the neuromuscular sys-
tem, where a special isoform secreted by 
The collagen IV network of the mature 
GBM consists primarily of α3α4α5 het-
erotrimers. Grafting experiments in vivo 
have shown that podocytes but not endo-
thelial cells synthesize the α3α4α5 net-
work,4 so it is likely the small amount of 
collagen α1 and α2(IV) chains that are 
present in the mature GBM derive mainly 
from glomerular endothelial cells. Similar 
to the situation for laminins discussed 
above, there are developmental transitions 
in collagen IV gene expression and colla-
gen trimer deposition during glomerulo-
genesis. At the earliest stages, only the α1 
and α2(IV) chains are detected, but as the 
glomerular capillaries begin to mature, 
there is a gradual increase in deposition of 
the α3, α4 and α5 chains.14 This devel-
opmental transition in collagen IV net-
work production has been shown to occur 
during human, dog and mouse kidney 
development.14,17,18
Nidogens
There are two nidogen proteins. Each is 
a dumbbell-shaped basement membrane 
component that binds tightly to the lam-
inin γ1 chain short arm as well as to type 
IV collagen.19 Therefore, nidogen was 
thought initially to be crucial for basement 
membrane formation as a potential link 
between the separate laminin and type IV 
Figure 3. schematic diagram showing that gBM breakdown due to Lama5 mutation results in 
failed glomerulogenesis. (A) A maturing wild-type (Lama5+/+) glomerulus with an intact podocyte 
epithelium (green) and endothelium (yellow) flanking the gBM (red). Mesangial cells (blue) are 
centrally located within the glomerulus, and parietal epithelial cells (not shown) sit on the Bow-
man’s capsule basement membrane (orange) and line Bowman’s space. (B) Failed glomerulogene-
sis in a Lama5-/- kidney. Discontinuities in the gBM (red) lead to stratification of the podocyte layer 




the remaining laminin β1 in the GBM 
is quantitatively insufficient compared to 
the level of laminin β2 that is normally 
present, and that artificially increasing 
the level of β1 will increase the concentra-
tion of laminin trimers in the GBM and 
thereby greatly improve the filtration bar-
rier, perhaps by increasing the density of 
the GBM.
Patients with what seem to be “less 
severe” missense LAMB2 mutations also 
have nephrotic syndrome, but it is accom-
panied by significantly milder extrare-
nal defects.42,43 These data suggest that 
laminin β2 and the laminin-521 trimer 
of which it is a component contribute to 
the glomerular filter by imparting appro-
priate barrier properties to the GBM. 
Indeed, our studies of Lamb2-/- mice 
showed clearly that albuminuria is detect-
able before foot process effacement and 
loss of slit diaphragms. Furthermore, foot 
process and slit diaphragm formation nor-
mally occurrs in the absence of LM-521. 
The straightforward interpretation is that 
albumin leaks across the filtration barrier 
because the GBM is defective, indicating 
that the GBM must normally serve as an 
important component of the filtration 
barrier. Loss of foot processes is likely a 
secondary response to proteinuria,41 but 
this remains to be investigated.
We recently investigated the mecha-
nism whereby a particular pathogenic 
LAMB2 missense mutation (R246Q) 
determinant of glomerular permselec-
tivity. It is important to note here that 
dominant mutations in human COL4A1, 
which encodes the collagen α1(IV) chain, 
also cause several forms of kidney disease, 
and there are a number of interesting 
extrarenal manifestations.34,35
In contrast to the delayed onset pro-
teinuria that develops in patients with 
Alport syndrome, those with Pierson 
syndrome, which is caused by truncat-
ing or severe missense mutations in the 
laminin β2 gene LAMB2, exhibit con-
genital nephrotic syndrome and diffuse 
mesangial sclerosis together with extra-
renal manifestation such as small pupils 
(microcoria) and neurological abnormali-
ties.36,37 Lamb2-/- mice exhibit a pheno-
type that is consistent with that observed 
in Pierson syndrome patients, including 
nephrotic syndrome,38 severe neuromus-
cular abnormalities39 and retinal defects.40 
Interestingly, unlike the GBM break-
down that occurs in mice lacking lam-
inin α5,24 GBM integrity is maintained 
in the absence of laminin β2. This is 
likely because there is retention of lam-
inin β1 in the mature Lamb2-/- GBM38 as 
part of LM-511 and ectopically deposited 
LM-111, LM-211 and perhaps LM-311.41 
We concluded initially that laminin β1 
compensates structurally for the miss-
ing laminin β2 but cannot compensate 
functionally.38 However, currently we are 
testing the alternative hypothesis that 
large cohort of genes expressed in podo-
cytes, the mutation of which in humans 
and/or mice causes defects in glomerular 
permselectivity, nephrotic range protein-
uria and in some cases, focal segmental 
glomerulosclerosis.27 This certainly lends 
support to the concept that podocytes are 
crucial for establishing and maintaining 
the glomerular filtration barrier. However, 
the GBM should not be ignored or for-
gotten.28 Of the nine proteins that are 
known to be present in the mature GBM, 
mutations that affect four of them cause 
glomerular disease in humans (as well as 
in mice), and mutation of a fifth causes 
nephrotic syndrome in mice.29 These will 
now be discussed.
The first GBM protein shown to be 
affected in a human disease is collagen 
α5(IV), which is encoded by COL4A5.30 
Mutations in COL4A5 cause the X-linked 
form of Alport syndrome, a hereditary 
glomerulonephritis leading to kidney fail-
ure.31 As discussed above, the α5 chain is 
a component of the α3α4α5(IV) trimer 
that is present in the mature GBM. In 
the absence of α5(IV), these trimers, and 
thus the network they would normally 
form within the GBM, are totally absent. 
Likewise, homozygous or compound het-
erozygous mutations that affect the auto-
somal COL4A3 or COL4A4 genes also 
prevent production of the α3α4α5(IV) 
trimer and cause the more rare, autosomal 
recessive form of Alport syndrome.
In the absence of the usual collagen 
α3α4α5(IV) network that is present in 
the GBM, there is substitution or com-
pensation by the (α1)
2
α2(IV) network.32 
Interestingly, in some Col4a3-/- Alport 
mice, especially those on the C57BL/6J 
strain background, there is also compen-
sation in the GBM by the (α5)
2
α6(IV) 
network, which may slow progression of 
the disease.33 Although this network func-
tions adequately for several years in most 
Alport syndrome patients, eventually there 
is a characteristic splitting and thickening 
of the GBM, visible by electron micros-
copy (Fig. 4), that sometimes imparts a 
“basket weave” appearance. This pathol-
ogy is associated first with hematuria and 
later with proteinuria. Because proteinuria 
is a relatively late feature of Alport syn-
drome, it seems that the identity of the 
collagen IV network is not an important 
Figure 4. The ultrastructure of Alport mouse gBM. in the absence of the collagen α3α45α5(iV) 
network, the gBM becomes split and thickened, with moderately electron-lucent outpocketings 
(asterisks). However, the endothelium and podocyte foot processes are mostly intact at this early 
stage of the disease process.
©2011 Landes Bioscience.
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School of Medicine: I have two ques-
tions. First, GBM is made by endothelial 
cells and podocytes, and I am wonder-
ing if anyone has looked carefully for any 
qualitative or quantitative differences 
between the contributions from these 
two cell types. Second, in the laminin β2 
knockouts, there is some β1 retention to 
partially compensate for the problem. Do 
you know if normally the β1 is from the 
podocyte or from the endothelial cells?
Dr. Miner: Dale Abrahamson has 
done a lot of work to address those issues, 
at least the first one. He has shown that 
the laminin is made by both, as he can 
detect LM-521 within the endoplasmic 
reticulum in both endothelial cells and 
in podocytes.2 My personal opinion is 
that podocytes make more, and that is 
based on our finding that we can rescue 
the laminin β2 knockout by only rescu-
ing the podocytes and not affecting the 
endothelial cells, which don’t express 
from the nephrin promoter that we used.45 
Regarding collagen, it is a different story. 
Dr. Abrahamson showed that only podo-
cytes make the collagen α3/4/5 network,4 
and that makes perfect sense because one 
can always detect a low level of the α1/2 
network on the subendothelial aspect of 
the basement membrane. So if one thinks 
about rescuing Alport syndrome, either 
by gene therapy or bone marrow stem 
cells, there would need to be an effect on 
the podocyte side. Your second question 
had to do with residual laminin β1 and 
where that comes from. That is something 
we don’t know and is something a stu-
dent in my laboratory is working on. My 
guess is that it is coming from both cells. 
Sometimes we can detect a little bit of β1 
even in a normal GBM, but I think the 
levels of transcription are very low, because 
these proteins are so long lived in the base-
ment membrane; turnover is very slow, so 
there never needs to be a lot of mRNA to 
make a basement membrane. I think it 
would be difficult for us to discover by in 
situ hybridization, for example, which cell 
is making β1. However, it is something we 
are interested in figuring out.
Dr. Raphael Kopan, Professor of 
Developmental Biology and of Medicine, 
Washington University School of 
Medicine: Have you looked to see if 
you have phenotypes in animals that are 
progresses to nephrotic syndrome and renal 
failure.29
Questions and Answers
Dr. Dwight Towler, Ira M. Lang Professor 
of Medicine and Developmental Biology, 
Washington University School of 
Medicine: I am curious about the poten-
tial for acquired dysfunctions in the lam-
inin β chains. On that particular Arg246 
of laminin β2, is it susceptible to modi-
fication by advanced glycation end prod-
ucts, for example? Do you know whether 
or not one or more N-carboxymethyl argi-
nine derivatives, advanced glycosylation 
end products described in collagen in the 
setting of diabetes, could also modify and 
nullify the function of that β chain?
Dr. Jeffrey Miner: I don’t think any-
one has looked at specific residues of lami-
nins in the setting of hyperglycemia.
Dr. Towler: The structure-function 
implications from the family with Pierson 
syndrome phenotypes and your elegant 
data point to that possibility. It is clearly 
an important region of laminin β2 with 
respect to glomerular basement membrane 
function and proteinuria; I was wondering 
whether or not some of the acquired albu-
minuria states and GBM deficiencies also 
relate to biochemical modifications of that 
same β2 arginine residue.
Dr. Miner: No, not that I know of.
Dr. Towler: I know this presentation 
was “focused on the filter,” but I was curi-
ous about your hypomorphic mutation of 
the α5 chain C terminus. Did you hap-
pen to note any structural defects that 
occurred in the peritubular basement 
membranes, where laminin-511 might be 
important?
Dr. Miner: We did not, we focused on 
the filter. That was the only place where 
we found any obvious abnormalities. The 
tubular basement membranes also have 
other laminins. It is not pure LM-511.
Dr. Towler: So do you think that 
the mesangial cell interaction with the 
COOH terminus of laminin α5 is a fairly 
specific interaction in the glomerular base-
ment membrane?
Dr. Miner: Yes
Dr. Feng Chen, Assistant Professor 
of Medicine and Cell Biology and 
Physiology, Washington University 
found in a Turkish family42 causes congeni-
tal nephrotic syndrome. The mutation was 
engineered into the rat laminin β2 cDNA 
and expressed in the podocytes of trans-
genic mice in vivo via the mouse nephrin 
promoter.44 Transgenes from three differ-
ent founder lines were expressed at differ-
ent relative levels, determined to be high, 
medium and low based on mutant protein 
accumulation in the GBM. These three 
transgenes were bred individually onto the 
Lamb2-/- background, so that all laminin 
β2 in the GBM derived from the mutant 
transgene. These mice developed protein-
uria, the level of which was inversely pro-
portional to the level of laminin β2 in the 
GBM and in all cases much lower than 
that observed in Lamb2-/- mice without the 
transgene. Interestingly, the low expressor 
had levels of laminin β2 mRNA in podo-
cytes that were higher than that normally 
observed for endogenous mouse laminin 
β2, suggesting that the nephrin promoter 
was more than adequate for driving the 
production of mutant laminin β2 mRNA, 
in agreement with our previous studies 
in reference 41 and 45. Because studies 
of the R246Q mutant in transfected 293 
cells suggest that the mutation somehow 
inhibits laminin secretion, we concluded 
that this mutation causes misfolding and 
degradation of most of the laminin β2 
polypeptide, but that the increased tran-
scription imparted by the nephrin pro-
moter allows the podocytes to overcome 
the secretion defect and secrete enough 
LM-521 into the GBM to make a partly 
functional albumin barrier.44
Concerning the other components 
of the GBM, lack of either nidogen-1 or 
nidogen-2 results in viable mice20 and no 
significant defects in glomerular filtration. 
Similarly, podocyte-specific knockout 
of agrin, which leads to its absence from 
the GBM, has no discernible effect on the 
filtration barrier, although its loss causes 
a dramatic reduction in the GBM’s con-
centration of negatively charged sites.23 
Finally, although no mutations affect-
ing human laminin α5 or laminin γ1 
have been discovered, likely due to early 
prenatal lethality that should occur due 
to widespread expression of both chains 
during embryogenesis, podocyte-spe-
cific mutation of Lama5 in mice results 
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is possible that the biopsy did not get the 
right glomeruli, and there might be leak-
ing glomeruli with foot process efface-
ment in other parts of the kidney.
Dr. Keith Hruska, Professor of 
Pediatrics, Medicine and Cell Biology 
and Physiology, Washington University 
School of Medicine: For your Col4a3 
model of Alport syndrome, you have 
reported the switch to the collagen 
α5/5/6(IV) network associated with 
improved renal function.33 You mentioned 
the potential for rescuing the laminin β2 
knockout with a small molecule stimulator 
of β1 expression. Has anybody been able 
to use this approach to activate a switch to 
induce podocytes to express ectopic α6 in 
the GBM?
Dr. Miner: You mean in mice? No. In 
theory, it should work in humans as well, 
but no one has ever seen that same ecto-
pic α5/5/6 collagen IV network in human 
Alport patients. It seems to be a mouse-
specific phenomenon and has only been 
shown to occur on the C57BL/6J back-
ground. The senior author of that paper 
thinks that there is actually a SNP, or a 
difference in the promoter of α5/6, that 
allows high levels of α6 to be made. And 
of course, most human Alport patients 
have α5 mutations, so even if you could 
activate α6 expression in podocytes, it 
would not help without the α5. So that 
approach couldn’t work for most patients.
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heterozygous for the β1 chain, the β2 
chain or trans-heterozygous for β1 and 
β2? Your hypothesis predicts that it is 
a quantitative rather than a qualitative 
deficiency.
Dr. Miner: In every laminin mutant 
that I know of there has never been a 
defect shown in a heterozygote. Even 
though it is quantitatively less transcrip-
tion, the proteins are so long lived that 
it doesn’t seem to take much mRNA to 
make a normal basement membrane pro-
tein complement.
Dr. Kopan: What if you reduce the β1 
on the β2 knockout background?
Dr. Miner: We haven’t done that. We 
have β1 knockout animals; we should do 
that experiment.
Dr. Helen Liapis, Professor of 
Pathology and Immunology, Washington 
University School of Medicine: You men-
tioned podocyte foot process effacement 
as being caused by a variety of condi-
tions, and your last diagram also points 
out that defects in a lot of molecules may 
lead to the same result. However, there are 
nephrotic syndromes that are not associ-
ated with foot process effacement. Can 
you try to explain that?
Dr. Miner: Well I know of endo-
thelial cell injury in preeclampsia, and 
that has been pretty well worked out by 
Karumanchi and others.46,47 Our model, 
I think, is also proteinuria without foot 
process effacement. What are the other 
instances?
Dr. Liapis: Well, my experience is 
in humans. For instance, you can have 
patients with crescentic glomerulonephri-
tis and lots of protein loss, but they do not 
have foot process effacement. We just had 
a pediatric case the other day, and I was 
scratching my head. Why does this kid 
have proteinuria, if the podocytes look 
normal and the foot processes are intact? 
Is it possible that you can have acquired 
laminin dysfunction?
Dr. Miner: I doubt it. It is possible 
that something is directly impacting the 
structure of the GBM, but I can’t imag-
ine why that might happen other than 
what Dr. Towler brought up. Thinking 
about the intact nephron hypothesis, it 
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